TSH Biopharm working together with InnoPharmax and Shandong Newtime Pharmacutical enter into global agreement of
2019.7.8
TSH Biopharm working together with InnoPharmax and Shandong Newtime Pharmacutical enter into global agreement of
TSH Biopharm (8432) and InnoPharmax today(7/8) announced granting Shandong Newtime Pharmaceutical an exclusive rights to commercialize pipeline product CRTA04, a treating chronic heart failure of ischemic agent in worldwide… View more
